Valeritas To Present At Investor Conferences In December 2016

BRIDGEWATER, N.J., Nov. 23, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer and Erick Lucera, Chief Financial Officer are scheduled to present at two investor conferences in December 2016.
Event:  The Benchmark Company Micro Cap Discovery One-on-One Conference
Format:  One-on-One Meetings   
Date:  Thursday, December 1, 2016   
Location: Chicago, IL  
     
Event:  LD Micro Main Event  
Format:  Presentation and One-on-One Meetings  
Date:  Wednesday, December 7, 2016  
Time:  9:30 a.m. PST   
Location: Bel Air, CA  

About Valeritas Holdings, Inc.Valeritas is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. Valeritas' flagship product, V-Go ® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for patients with Type 2 diabetes that enables patients to administer a continuous preset basal rate of insulin over 24 hours. It also provides on-demand bolus dosing at mealtimes.  It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in a state-of-the-art facility in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com.
Investor Contacts:Nick Laudico / Robert Flamm, Ph.D.The Ruth Group(646)536-7030 / 7017IR@valeritas.comOrThe Del Mar Consulting Group, Inc.Robert B. Prag, President858-794-9500bprag@delmarconsulting.comMedia Contact:Christopher HippolyteThe Ruth Group(646)536-7023PR@valeritas.com